Skip to main content

Branded

  • Allergan to acquire Vitae Pharmaceuticals

    DUBLIN and FORT WASHINGTON, Pa. — Allergan will be expanding its dermatology pipeline with its plan to acquire Vitae Pharmaceuticals. The acquisition, which was announced Wednesday and has been approved by the boards of both companies, will see the Allergan paying about $631 million in cash for the clinical-stage biotechnology company. 
     

  • Latest CDC report underscores importance in HBP medication adherence

    ATLANTA - Some 5 million Medicare Part D enrollees age 65 and older are not taking their blood pressure medicine properly, increasing their risk of heart disease, stroke, kidney disease and death, according to a new Vital Signs report from the Centers for Disease Control and Prevention released Tuesday.

  • Merck Manual professional app update makes mobile reference guide free

    KENILWORTH, N.J. — A new update to the mobile app for the Merck Manual for Healthcare Professionals is broadening access to the reference guide. Merck announced Thursday that with the latest update, the app is entirely redesigned and free. Once the app is downloaded, its content is saved offline so it can be accessed with or without an Internet connection. 
     

  • Upsher-Smith launches savings, support program for Qudexy XR

    MAPLE GROVE, Minn. — Upsher-Smith Laboratories on Thursday announced a new savings and support program for its anti-epileptic drug Qudexy XR, called “It’s That Simple.” The program makes the drug available to eligible patients for a $0 copay. 
     

  • Flu shot now available across Wegmans

    ROCHESTER, N.Y. – The influenza vaccine for the 2016-2017 flu season is now available at all Wegmans Food Markets locations, the supermarket chain announced Thursday.

    “By offering the flu vaccination in our pharmacies, we’re making it easy for our customers to protect themselves from the seasonal flu, while also improving immunization rates in the communities we serve,” stated Katie Niles, Wegmans pharmacist and pharmacy clinical wellness services manager.
     

  • Express Scripts rolls out value program around inflammatory conditions

  • FDA approves expanded indication for Amgen's Blincyto

    SILVER SPRING, Md. — The Food and Drug Administration has approved Amgen’s supplemental Biologics License Application for an expanded indication for its Blincyto, the company said Thursday. 
     
    The drug is now approved for treatment of pediatric patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. The indication was granted under accelerated approval. 
     

  • PhRMA unveils new ads for ‘From Hope to Cures’ campaign

    WASHINGTON — The Pharmaceutical Research and Manufacturers on Tuesday rolled out new advertising as part of its “From Hope to Cures Campaign,” sharing two patient stories that focus on the theme of “Achievable.”
     
X
This ad will auto-close in 10 seconds